Penn team shines a light on blood disorder

Investigators at the Perelman School of Medicine at the University of Pennsylvania. say they have reached some new insights into the structure of a protein complex that is a root cause of a clotting disorder (heparin-induced thrombocytopenia) that strikes patients who receive the anti-clotting drug heparin. Their work was published in Nature Communications. Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.